112 related articles for article (PubMed ID: 9678717)
1. The correlation of telomerase and IL-10 with leukemia transformation in a mouse model of chronic lymphocytic leukemia (CLL).
Peng B; Zhang M; Sun R; Lin YC; Chong SY; Lai H; Stein D; Raveche ES
Leuk Res; 1998 Jun; 22(6):509-16. PubMed ID: 9678717
[TBL] [Abstract][Full Text] [Related]
2. A cultured malignant B-1 line serves as a model for Richter's syndrome.
Peng B; Sherr DH; Mahboudi F; Hardin J; Wu YH; Sharer L; Raveché ES
J Immunol; 1994 Aug; 153(4):1869-80. PubMed ID: 8046247
[TBL] [Abstract][Full Text] [Related]
3. The NZB mouse as a model for chronic lymphocytic leukemia.
Phillips JA; Mehta K; Fernandez C; Raveché ES
Cancer Res; 1992 Jan; 52(2):437-43. PubMed ID: 1370214
[TBL] [Abstract][Full Text] [Related]
4. H-2z homozygous New Zealand mice as a model for B-cell chronic lymphocytic leukemia: elevated bcl-2 expression in CD5 B cells at premalignant and malignant stages.
Okamoto H; Nishimura H; Shinozaki A; Zhang D; Hirose S; Shirai T
Jpn J Cancer Res; 1993 Dec; 84(12):1273-8. PubMed ID: 7507474
[TBL] [Abstract][Full Text] [Related]
5. Cytokine gene expression in B-cell chronic lymphocytic leukemia: evidence of constitutive interleukin-8 (IL-8) mRNA expression and secretion of biologically active IL-8 protein.
di Celle PF; Carbone A; Marchis D; Zhou D; Sozzani S; Zupo S; Pini M; Mantovani A; Foa R
Blood; 1994 Jul; 84(1):220-8. PubMed ID: 7517209
[TBL] [Abstract][Full Text] [Related]
6. Cell cycle effects of IL-10 on malignant B-1 cells.
Yen Chong S; Lin YC; Czarneski J; Zhang M; Coffman F; Kashanchi F; Raveche E
Genes Immun; 2001 Aug; 2(5):239-47. PubMed ID: 11528515
[TBL] [Abstract][Full Text] [Related]
7. Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function.
DiLillo DJ; Weinberg JB; Yoshizaki A; Horikawa M; Bryant JM; Iwata Y; Matsushita T; Matta KM; Chen Y; Venturi GM; Russo G; Gockerman JP; Moore JO; Diehl LF; Volkheimer AD; Friedman DR; Lanasa MC; Hall RP; Tedder TF
Leukemia; 2013 Jan; 27(1):170-82. PubMed ID: 22713648
[TBL] [Abstract][Full Text] [Related]
8. CD5 promotes IL-10 production in chronic lymphocytic leukemia B cells through STAT3 and NFAT2 activation.
Garaud S; Morva A; Lemoine S; Hillion S; Bordron A; Pers JO; Berthou C; Mageed RA; Renaudineau Y; Youinou P
J Immunol; 2011 Apr; 186(8):4835-44. PubMed ID: 21398617
[TBL] [Abstract][Full Text] [Related]
9. Requirement for increased IL-10 in the development of B-1 lymphoproliferative disease in a murine model of CLL.
Ramachandra S; Metcalf RA; Fredrickson T; Marti GE; Raveche E
J Clin Invest; 1996 Oct; 98(8):1788-93. PubMed ID: 8878429
[TBL] [Abstract][Full Text] [Related]
10. A model of chronic lymphocytic leukemia with Ritcher's transformation in severe combined immunodeficiency mice.
Su YC; Wu WM; Wu MF; Chiang BL
Exp Hematol; 2001 Oct; 29(10):1218-25. PubMed ID: 11602324
[TBL] [Abstract][Full Text] [Related]
11. IL-4 and interferon gamma regulate expression of inducible nitric oxide synthase in chronic lymphocytic leukemia cells.
Levesque MC; Misukonis MA; O'Loughlin CW; Chen Y; Beasley BE; Wilson DL; Adams DJ; Silber R; Weinberg JB
Leukemia; 2003 Feb; 17(2):442-50. PubMed ID: 12592345
[TBL] [Abstract][Full Text] [Related]
12. Expression of interleukin 10 in B lymphocytes of different origin.
Finke J; Ternes P; Lange W; Mertelsmann R; Dölken G
Leukemia; 1993 Nov; 7(11):1852-7. PubMed ID: 7694007
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic analysis of receptor-ligand pairs on B-cells in B-chronic lymphocytic leukemia.
Gagro A; Dasić G; Sabioncello A; Rabatić S; Reckzeh B; Havemann K; Kardum I; Jacksić B; Vitale B
Leuk Lymphoma; 1997 Apr; 25(3-4):301-11. PubMed ID: 9168440
[TBL] [Abstract][Full Text] [Related]
14. Regulatory role of T cells in a murine model of lymphoproliferative disease.
Raveche E; Fernandes H; Ong H; Peng B
Cell Immunol; 1998 Jul; 187(1):67-75. PubMed ID: 9682005
[TBL] [Abstract][Full Text] [Related]
15. TLR2 Expression on Leukemic B Cells from Patients with Chronic Lymphocytic Leukemia.
Szymańska A; Bojarska-Junak A; Drobiecki A; Tomczak W; Roliński J; Hus M; Hus I
Arch Immunol Ther Exp (Warsz); 2019 Feb; 67(1):55-65. PubMed ID: 30196472
[TBL] [Abstract][Full Text] [Related]
16. Growth inhibition of malignant CD5+B (B-1) cells by antisense IL-10 oligonucleotide.
Peng B; Mehta NH; Fernandes H; Chou CC; Raveché E
Leuk Res; 1995 Mar; 19(3):159-67. PubMed ID: 7535370
[TBL] [Abstract][Full Text] [Related]
17. RNA interference of IL-10 in leukemic B-1 cells.
McCarthy BA; Mansour A; Lin YC; Kotenko S; Raveche E
Cancer Immun; 2004 Jul; 4():6. PubMed ID: 15270555
[TBL] [Abstract][Full Text] [Related]
18. PKCbeta is essential for the development of chronic lymphocytic leukemia in the TCL1 transgenic mouse model: validation of PKCbeta as a therapeutic target in chronic lymphocytic leukemia.
Holler C; Piñón JD; Denk U; Heyder C; Hofbauer S; Greil R; Egle A
Blood; 2009 Mar; 113(12):2791-4. PubMed ID: 19168795
[TBL] [Abstract][Full Text] [Related]
19. Lack of TIR8/SIGIRR triggers progression of chronic lymphocytic leukemia in mouse models.
Bertilaccio MT; Simonetti G; Dagklis A; Rocchi M; Rodriguez TV; Apollonio B; Mantovani A; Ponzoni M; Ghia P; Garlanda C; Caligaris-Cappio F; Muzio M
Blood; 2011 Jul; 118(3):660-9. PubMed ID: 21652674
[TBL] [Abstract][Full Text] [Related]
20. Cd1d regulates B cell development but not B cell accumulation and IL10 production in mice with pathologic CD5(+) B cell expansion.
Palmer VL; Nganga VK; Rothermund ME; Perry GA; Swanson PC
BMC Immunol; 2015 Nov; 16():66. PubMed ID: 26537916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
